Introduction
decompensated liver cirrhosis, Cirrhosis, end-stage liver disease, fibrosis
CIRRHOSIS, FIBROSIS, LIVER DISEASE, LIVER CIRRHOSIS
Cirrhosis is a diffuse liver disease, which is pathologically characterized by the occurrence of significant fibrosis and the formation of pseudolobules.Basic and clinical studies in recent years have shown that stem cell therapy has the potential to become an effective alternative therapy for the treatment of liver cirrhosis.Prior studies have shown that HUCB-MSCs can safely and effectively improve liver function as shown by improvements to Child-Turcotte-Pugh (CTP) and model for end-stage liver disease (MELD) scores in patients with liver cirrhosis.This study aimed to evaluate the impact of HUCB-MSCT on long-term outcomes of patients with decompensated liver cirrhosis (DLC).